Charles River Laboratories Lifts Annual Outlook- Update
(RTTNews) - Charles River Laboratories International, Inc. (CRL), a provider of drug discovery and development services, Wednesday raised its 2026 outlook for organic revenue growth and earnings per share.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.